Otology and Neurotology 37 8

Otology and Neurotology, 37(8) 

1.     Introduction to the Pharmaceutical Interventions for Hearing Loss Clinical Research Guidance Papers

Hammill, Tanisha L.; Packer, Mark

Otology & Neurotology. 37(8):e261-e262, September 2016.

2.     The Genomic Basis of Noise-induced Hearing Loss: A Literature Review Organized by Cellular Pathways

Clifford, Royce Ellen; Hoffer, Michael; Rogers, Rick

Otology & Neurotology. 37(8):e309-e316, September 2016.

3.     Oxidative Damage and Inflammation Biomarkers: Strategy in Hearing Disorders

Haase, Gerald M.; Prasad, Kedar N.

Otology & Neurotology. 37(8):e303-e308, September 2016.

4.     Speech-in-Noise Tests and Supra-threshold Auditory Evoked Potentials as Metrics for Noise Damage and Clinical Trial Outcome Measures

Le Prell, Colleen G.; Brungart, Douglas S.

Otology & Neurotology. 37(8):e295-e302, September 2016.

5.     Serial Monitoring of Otoacoustic Emissions in Clinical Trials

Konrad-Martin, Dawn; Poling, Gayla L.; Dreisbach, Laura E.; Reavis, Kelly M.; McMillan, Garnett P.; Lapsley Miller, Judi A.; Marshall, Lynn

Otology & Neurotology. 37(8):e286-e294, September 2016.

6.     “Measurement” of Tinnitus

Henry, James A.

Otology & Neurotology. 37(8):e276-e285, September 2016.

7.     Temporary and Permanent Noise-induced Threshold Shifts: A Review of Basic and Clinical Observations

Ryan, Allen F.; Kujawa, Sharon G.; Hammill, Tanisha; Le Prell, Colleen; Kil, Jonathan

Otology & Neurotology. 37(8):e271-e275, September 2016.

8.     Guidelines for Auditory Threshold Measurement for Significant Threshold Shift

Campbell, Kathleen; Hammill, Tanisha; Hoffer, Michael; Kil, Jonathan; Le Prell, Colleen

Otology & Neurotology. 37(8):e263-e270, September 2016.